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Nerve growth factor (NGF) rapidly increases the cyclic GMP (cGMP) level about 2-3-fold and enhances the cGMP phos- 
phodiesterase (PDE) activity about 2-fold in rat pheochromocytoma PC12 cells. No changes in the level of cyclic AMP 
(CAMP) and in the activity of CAMP PDE were found. GTP and a nonhydrolysable analog of GTP, GMP-PCP, at 
100 PM, were able to mimic the effect of NGF on the cGMP PDE activity. These results suggest that the cGMP system 
may be one of the second messengers of NGF action in PC12 cells. 
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1. INTRODUCTION 
Nerve growth factor (NGF) is a target-derived 
trophic protein regulating the survival, develop- 
ment, and maintenance of sympathetic and some 
sensory neurons [l]. In PC12 cells, NGF induces 
outgrowth of neurites, increases electric excitabili- 
ty and the amount of acetylcholine receptors [2]. 
NGF also induces some rapid changes in PC12 
cells, such as the phosphorylation of several pro- 
teins, activation of c-fos and ,&actin genes, 
redistribution of F-actin, etc. [2-51. Although the 
mode of action of NGF in various cell types has 
been well studied, the question about the second 
messengers involved in the action of NGF is 
unclear. The evidence concerning the participation 
of classical second messengers - cyclic nucleotides, 
and especially CAMP, in the mechanism of NGF 
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action is conflicting [3,6- 171. Moreover, very little 
is known about the behaviour of the cGMP system 
in NGF-treated PC12 cells. For this reason we 
decided to reinvestigate the possible role of cyclic 
nucleotides in the action of NGF on PC12 cells. 
Here we provide experimental evidence that the 
cGMP system may be one of the second 
messengers of NGF action in PC12 cells. 
2. MATERIALS AND METHODS 
PC12 cells (kindly provided by Dr J. Patrick, Salk Institute) 
were grown in DMEM medium (Sigma, USA) containing 10% 
horse serum. For cyclic nucleotide assay, suspended cells were 
sedimented by centrifugation and resuspended in Tyrode 
physiological saline (pH 7.4) or RPM1 medium (Sigma) and 
preincubated at 37°C for 10 min. A sample for the determina- 
tion of the basal levels of cyclic nucleotides was taken just 
before the treatment of PC12 cells with mouse 7 S NGF (pro- 
vided by Dr V. Kalyunov, Minsk). During 10 min after the 
treatment of PC12 cells with NGF, 6021 samples of cell suspen- 
sion were collected at I-min intervals and transferred to 100 ,x1 
ice-cold 10% trichloroacetic acid. IBMX (Serva, FRG), an in- 
hibitor of phosphodiesterase (PDE), was added 5 min before 
NGF. The content of cGMP and CAMP in collected samples 
was determined by the standard procedure with CAMP and 
cGMP “‘1 RIA Kits (Chemapol, Czechoslovakia). 
For measurements of the cGMP PDE and CAMP PDE activi- 
ty the suspension of PC12 cells was incubated with 7 S NGF 
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(100 ng/ml) from 1 to 10 min at 37’C. The cells were 
sedimented by centrifugation and homogenized in ice-cold 
40 mM Tris-HCI buffer, pH 7.8, 5 mM MgClz. The PDE ac- 
tivity was measured in 40 pl homogenization buffer containing 
20 pM [8-3H]cGMP or 20 pM [8-‘HIcAMP, respectively 
(Isotop, USSR). In some experiments the incubation buffer also 
included 1OOpM GTP or 1OOpM GMP-PCP (Boehringer 
Mannheim, FRG). The samples were incubated for 15 min at 
37”C, the reaction being stopped by adding 40 ,~l ice-cold 10% 
trichloroacetic acid. The reaction products were separated on 
Silufol 254 TLC plates (Kavalier, Czechoslovakia) [18]. The 
spots were visualized under UV light and the radioactivity 
counted in 5 ml dioxane-based scintillation fluid using a 
Rackbeta (LKB, Sweden) liquid scintillation counter. Protein 
was determined by the method of Lowry et al. [19]. 
For studying the NGF-triggered F-actin redistribution of 
PC12 cells, cells were grown on glass coverslips coated with 
poly-L-lysine (Serva) and stained with rhodamine-phalloidin 
1201. 
3. RESULTS AND DISCUSSION 
3.1. CAMP and cGMP levels after treatment with 
NGF 
If cyclic nucleotides serve as second messengers 
in the action of NGF, then their intracellular level 
in target cells must change in response to NGF 
within a few minutes. In the first series of ex- 
periments, PC12 cells were preincubated with 
0.1 mM IBMX. IBMX is an inhibitor of PDE 
widely used in studying changes in levels of cyclic 
nucleotides in cells. In the presence of IBMX the 
level of CAMP and cGMP in NGF-treated PC12 
cells remains unchanged. 
In the second series, the content of cGMP and 
CAMP was measured in PC12 cells in the absence 
of IBMX. Under these conditions, NGF increases 
the intracellular cGMP level about 2-3-fold within 
a few minutes. After 6 min of stimulation with 
NGF the cGMP level reaches a plateau (fig.1). 
Statistically significant changes in CAMP level 
were not observed (fig.1). A possible explanation 
for the increase in cGMP level only in the absence 
of IBMX is that NGF regulates the activity of 
cGMP PDE rather than that of guanylate cyclase. 
Therefore, we assumed that NGF may inhibit the 
activity of cGMP PDE and the latter may lead to 
the accumulation of cGMP within the cells. 
3.2. cGMP PDE activity changes in PC12 cells 
treated with NGF 
Surprisingly, direct measurement of cGMP PDE 
activity shows that NGF does not inhibit but 
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Fig. 1. Effect of NGF on the levels of cGMP (0) and CAMP (0) 
in PC12 cells. 100% - the levels of cGMP and CAMP in control 
cells (not treated with NGF). 
stimulates the cGMP PDE activity about 2-fold 
(fig.2). This stimulation occurs very rapidly; the 
increase in activity was completed within 1 min of 
the treatment with NGF. At the same time NGF 
had no effect on the activity of CAMP PDE (fig.2). 
The data on receptor-mediated PDE activity 
regulation in other systems indicate that in this 
1 
CAMP POE cGMP POE 
C NGF C NGF GMP-GTP NGF 
PCP GMP-PCP 
Fig.2. Effects of NGF, GTP and GMP-PCP on CAMP PDE 
and CAMP PDE activities in PC12 cells. 100% - the CAMP 
PDE and cGMP PDE activities in control cells (not treated with 
NGF). NGF, 100 ng/ml; GTP and GMP-PCP, 1OOpM. 
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process a guanine nucleotide regulatory protein 
(G-protein) is involved [21-231. For example, a 
well-characterized G-protein, transducin, couples 
the light-activated receptor (rhodopsin) of the 
retinal rod outer segment o activation of a cGMP 
PDlE 5241. It has been popased L!&L &e NC& 
receptor may also be coupled with G-like protein. 
This assumption is supported by the facts that 
microinjection of G-like ras protein p21 into PC12 
cells causes the 0u~groWh 02 neurites simi>ar to 
that induced by NGF [25,26] and that neurite 
outgrowth induced by NGF in PC12 cells is in- 
hibited by microinjection of monoclonal an- 
tibcdies &a Harvey v-cas $?I (277, Examination 
of the NGF receptor amino acid sequence has 
shown that the portion of the NGF receptor ex- 
tenting in10 the cytoplasm is Jarpe enouph 10 
possess an enzymatic activity or to interact with 
other proteins that may mediate signal transduc- 
tion [28]. 
If G-protein is involved in the regulation of 
cGMP PDE activity in PC12 cells, then GTP or its 
nonhydrolysable analogs ought to mimic the ac- 
tion of NGF. We investigated this possibility and 
showed that GTP and GMP-PCP (a nonhydrolys- 
able analog of GTP) are indeed able to stimulate 
the increase in cGMP PDE activity in homogenates 
of PC12 cells (fig.2). The stimulatory effects of 
NGF and GhPf-PCP were not additive {fig.2). 
This indicates that the regulation of PDE activity 
by NGF and GMP-PCP may occur through the 
same effector system. In fact, these experiments 
support the idea that G-like protein is involved in 
the regulation of cGMP PDE activity in PC12 
cells. Furt.hermore, our preliminary experiments 
indicate that G-protein which is involved in the ac- 
tion of NGF can be blocked by pertussis toxin 
(PT<. u?L <ncudaribn or” tfie cell5 wtifi IrK no 
stimulation of cGMP PDE activity by NGF was 
elicited {not. shown). 
Ttie questibn arfies asp tO_ wttetier r’ttere ti any 
evidence on the physiological role of regulation of 
cGMP PDE activity by NGF. According to our 
previous data, IVGF causes rapid redistribution of 
F-a&n ‘m TL’<L c&s :f$. 3nzk-mkden 0% -XX-L 
celIs for 30-60 s with 0.1 mM IBMX prior to NGF 
treatment blocks the redistribution of F-actin 
(fig.3). Unfortunate>y, ‘IBMX is not a sped&c in- 
hit&or far tke cGMP PUE, acsa inhibiting the ac- 
tivity of CAMP PDE. Therefore, we do not know 
F&.3. E%xr uf IB&fX UrI NGF-‘-irrL?uLTc? cedktributicrll CrF F- 
actin in PC12 cells: (A) untreated, (B) treated with NGF 
(50 ng/ml) for 10 min, (C) treated simultaneously with NGF 
and IBMX (0.1 mhl) for 10 min. Cells were staked with 
rhodamine-qhalloidin:, maqxification.. 600 x 
whether the effect of IBMX is due to the increased 
%a%~& &v& 05 Yne5e -nu&eo1i&e5 or, inbee& 10 t’ne 
blockage of the NGF-induced increase in cGMP 
level (see above). During long-term incubation, 
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IBMX, analogously to theophylline [29], does not 
prevent the outgrowth of neurites in PC12 cells. 
Thus, the rapid and long-term responses caused by 
NGF may be independent of each other. 
The regulation of cGMP PDE activity by NGF 
in PC12 cells is similar to that by light-activated 
receptors of the retinal rod outer segment. Hence, 
one can speculate that in PC12 cells, as in retinal 
rods, the main role is played by cGMP, regulating 
the movement of Na+ and K+ through the mem- 
brane. In this case, cGMP PDE has the function of 
regulating the cGMP level. This hypothesis is sup- 
ported by data showing that NGF regulates the 
permeability of membranes of chick embryo 
ganglionic neurons and PC12 cells for Na+ and K’ 
[30-331 and that Na’ responses to NGF are in- 
dependent of CAMP [34]. 
Another question to arise concerns the reason 
why, in spite of the NGF-induced increase in 
cGMP PDE activity, the intracellular level of 
cGMP also increases. We suppose that the increase 
in cGMP level after NGF treatment may be ex- 
plained by the enhanced guanylate cyclase activity 
or the compartmentalization of cGMP and cGMP 
PDE in PC12 cells. In the first case, the activation 
of guanylate cyclase activity in PC12 cells must be 
related to the influence of NGF on the PDE, since 
IBMX, a PDE inhibitor, blocked the NGF- 
mediated increase in cGMP level. However, fur- 
ther experimental evidence is needed. Taken 
together, our results with PC12 cells indicate that 
the cGMP system may be one of the second 
messenger systems in the action of NGF. 
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